August 31 2023 - Sage lays off 40%, shakes up C-suite to squeeze a profit out of partially rejected zuranolone

Sage lays off 40%, shakes up C-suite to squeeze a profit out of partially rejected zuranolone
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst
AI is a game changer for toughest areas of drug discovery
*please scroll down for all the latest news*

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraudt;